MiNK Therapeutics, Inc. (NASDAQ: INKT) revealed in an 8-K filing on January 17, 2025, that the company has gained approval for a reverse stock split. The Special Meeting of Stockholders held on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback